Public domain

Supports face-to-face training to review results from research conducted by the NIDA CTN comparing detoxification with buprenorphine versus clonidine. Provides instruction for implementing this protocol in treatment settings, including methods of evaluation and induction, the taper schedule, and use of ancillary medications during treatment.

Gives patients information on buprenorphine and MAT for opioid addiction. Describes addiction and withdrawal and how buprenorphine works, its proper use, its side effects, and how it fits with counseling in the recovery process.

Highlights the findings of the NIDA Clinical Trials Network study that compared longer term versus short-term buprenorphine/naloxone treatment in an outpatient setting. Examines opioid use, treatment with buprenorphine, and further implications for young adults with opioid addiction.

Gives patients information on naltrexone and MAT for opioid addiction. Describes addiction and withdrawal and how naltrexone works, its proper use, its side effects, and how it fits with counseling in the recovery process.

Provides an overview of science-based solutions for treating patients with opioid addiction.

Provides facts about the benefits of using PDMPs for prescribers, pharmacists, patients, and regulatory and law enforcement agencies.

Offers awareness training to disseminate information and enhance awareness among multidisciplinary (nonphysician) addiction professionals about buprenorphine treatment. Provides a broad overview of the medication, its effects, and the role of nonphysician practitioners.

Introduces health professionals, students, and primary care residents to a standardized approach to the management of patients with chronic nonmalignant pain that integrates techniques for the prevention and detection of misuse of prescription opioids.

Teaches medical providers how to recognize and manage aberrant behaviors in patients taking prescription opioids, such as drug misuse or diversion; how to terminate opioid treatment and transition patients to alternative types of care; and how to manage disruptive or threatening patient behaviors that may arise when discontinuing opioids.

Helps clinicians screen their patients for SUDs, conduct brief interventions for patients in the early stages of problem development, and appropriately refer more severely affected patients for indepth assessment and treatment.